BRAF and colorectal carcinoma: In the present study, among MSI-H CRC tumors, the rate of CIMP-high was 25% and the rate of BRAF mutation was 22.8%, which was lower than that in the study by Ogino et al. among a Western population (72.7% CIMP-H and 45% BRAF mutation) [14].